Filing Flows › Arrowhead Pharmaceuticals (ARWR) › How it makes money
How Arrowhead Pharmaceuticals (ARWR) makes money
Arrowhead Pharmaceuticals (ARWR) made $75.3M of revenue in the third quarter fiscal 2026 (Q3 FY26), +171% from a year earlier.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q3 FY26 | % of revenue |
|---|---|---|
| Revenue | $75.3M | 100.0% |
| Income tax | $11K | 0.0% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q3 FY26 | $75.3M | +171% |
| Q2 FY26 | $73.7M | -86% |
| Q1 FY26 | $264M | 106× |
| Q4 FY25 | $256M | — |
| Q3 FY25 | $27.8M | — |
| Q2 FY25 | $543M | — |
From Arrowhead Pharmaceuticals' 10-Q filed Aug 4, 2026 (on EDGAR).
Questions
How does Arrowhead Pharmaceuticals make money?
Arrowhead Pharmaceuticals (ARWR) made $75.3M of revenue in the third quarter fiscal 2026 (Q3 FY26), +171% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.